Pharmacokinetic and Pharmacodynamic study of Temsirolimus in Renal Cell Carcinoma Patients [Estudio farmacocinetico y farmacodinamico de temsirolimus en pacientes con carcinoma de celulas renales].

Trial Profile

Pharmacokinetic and Pharmacodynamic study of Temsirolimus in Renal Cell Carcinoma Patients [Estudio farmacocinetico y farmacodinamico de temsirolimus en pacientes con carcinoma de celulas renales].

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Mar 2012

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Renal cell carcinoma
  • Focus Biomarker; Pharmacokinetics
  • Most Recent Events

    • 29 Mar 2012 Planned end date changed from 20 Dec 2012 to 20 Dec 2013 as reported by European Clinical Trials Database.
    • 27 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top